Literature Collection

Collection Insights

9K+

References

8K+

Articles

1000+

Grey Literature

3500+

Opioids & SU

The Literature Collection contains over 9,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

9421 Results

7581

State mandates for mental health parity an effective tool in reducing unmet need for mental health care?

Type: Web Resource

Year: 2008

Source:

State mandates for mental health parity an effective tool in reducing unmet need for mental health care? 2008.

Abstract: Thesis (M.A.)--Georgetown University, 2008. Title from caption (viewed on Nov. 25, 2008). Mode of access: World Wide Web. Includes bibliographical references.

Topic(s):

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Export Citation: RIS

7582

State Maternal Mortality Review Committees (MMRCs) Address Substance Use Disorder and Mental Health to Improve Maternal Health

Type: Report

Authors: Taylor Platt, Carrie Hanlon

Year: 2021

Source:

Platt T, Hanlon C. State Maternal Mortality Review Committees (MMRCs) Address Substance Use Disorder and Mental Health to Improve Maternal Health. Washington, D.c.: National Academy for State Health Policy (NASHP); 2021.

Publication Place: Washington, D.C.

Topic(s):

, , ,

Disclaimer:

Grey literature is comprised of materials that are not made available through traditional publishing avenues. Examples of grey literature in the Repository of the Academy for the Integration of Mental Health and Primary Care include: reports, dissertations, presentations, newsletters, and websites. This grey literature reference is included in the Repository in keeping with our mission to gather all sources of information on integration. Often the information from unpublished resources is limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

7583

State mental health policy: mending Missouri's safety net: transforming systems of care by integrating primary and behavioral health care

Type: Journal Article

Authors: D. Schuffman, B. G. Druss, J. J. Parks

Year: 2009

Source:

Schuffman D, Druss BG, Parks JJ. State mental health policy: mending Missouri's safety net: transforming systems of care by integrating primary and behavioral health care. Psychiatric Services (Washington, D.c.) 2009;60:585-588, . https://doi.org/10.1176/appi.ps.60.5.585.

Publication Place: United States

Abstract: Missouri has begun a three-year pilot program across the state to integrate the primary care services provided by federally qualified health centers (FQHCs) and the behavioral health services provided by community mental health centers (CMHCs). This column describes the integration initiative, in which start-up funds were provided in 2008 to seven FQHC-CMHC partnerships (a total of $700,000 to each pair over 3.5 years). It reviews lessons learned during the first year of the project in bringing these two very different public systems of care together to mend the public health safety net.

Topic(s):

Pubmed

Reference Links:

Pubmed

Export Citation: RIS

7584

State of the art in substance use prevention and early intervention: Applications to pediatric primary care settings

Type: Journal Article

Authors: Pamela A. Matson, Ty Ridenour, Nicholas Ialongo, Richard Spoth, Guillermo Prado, Christopher J. Hammond, J. D. Hawkins, Hoover Adger

Year: 2021

Source:

Matson PA, Ridenour T, Ialongo N, Spoth R, Prado G, Hammond CJ, et al. State of the art in substance use prevention and early intervention: Applications to pediatric primary care settings. Prevention Science 2021. https://doi.org/10.1007/s11121-021-01299-4.

Topic(s):

,

Reference Links:

Export Citation: RIS

7585

State Options for Integrating Physical and Behavioral Health Care

Type: Government Report

Authors: Centers for Medicare & Medicaid Services

Year: 2011

Source:

Services C for M & M. State Options for Integrating Physical and Behavioral Health Care 2011.

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (647.12 KB)

Reference Links: PDF (647.12 KB)

Export Citation: RIS

7586

State Partnerships for First-Episode Psychosis Services

Type: Journal Article

Authors: S. M. Essock, H. H. Goldman, M. F. Hogan, B. M. Hepburn, L. I. Sederer, L. B. Dixon

Year: 2015

Source:

Essock SM, Goldman HH, Hogan MF, Hepburn BM, Sederer LI, Dixon LB. State Partnerships for First-Episode Psychosis Services. Psychiatric Services (Washington, D.c.) 2015. https://doi.org/10.1176/appi.ps.201400117.

Abstract: The RAISE (Recovery After an Initial Schizophrenia Episode) Connection Program was a partnership that involved state mental health authorities (SMHAs) in Maryland and New York with research funding from the National Institute of Mental Health. The SMHAs collaborated with researchers to implement a team-based approach designed to serve people with newly emerged schizophrenia to maximize recovery and minimize disability. This column explains why states are interested in first-episode psychosis services and describes the development of the successful partnership, financing mechanisms, and plans to add teams in both states.

Topic(s):

, ,

Pubmed

Reference Links:

Pubmed

Export Citation: RIS

7587

State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants

Type: Journal Article

Authors: J. M. Harrison, R. Kerber, B. Andraka-Christou, M. Sorbero, B. D. Stein

Year: 2022

Source:

Harrison JM, Kerber R, Andraka-Christou B, Sorbero M, Stein BD. State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants. Medical Care Research And Review : Mcrr 2022:10775587221086489+. https://doi.org/10.1177/10775587221086489.

Publication Place: United States

Abstract:

Nurse practitioner (NP) and physician assistant (PA) prescribing can increase access to buprenorphine treatment for opioid use disorder. In this cross-sectional study, we used deidentified claims from approximately 90% of U.S. retail pharmacies (2017-2018) to examine the association of state policies with the odds of receiving buprenorphine treatment from an NP/PA versus a physician, overall and stratified by urban/rural status. From 2017 to 2018, the percentage of buprenorphine treatment episodes prescribed by NPs/PAs varied widely across states, from 0.4% in Alabama to 57.2% in Montana. Policies associated with greater odds of buprenorphine treatment from an NP/PA included full scope of practice (SOP) for NPs, full SOP for PAs, Medicaid pay parity for NPs (reimbursement at 100% of the fee-for-service physician rate), and Medicaid expansion. Although most findings with respect to policies were similar in urban and rural settings, the association of Medicaid expansion with NP/PA buprenorphine treatment was driven by rural counties.

Topic(s):

, ,

Pubmed

Reference Links:

Pubmed

Export Citation: RIS

7588

State Policy Levers for Expanding Family-Centered Medication-Assisted Treatment

Type: Government Report

Authors: Julie Seibert, Holly Stockdale, Rose Feinberg, Erin Dobbins, Elysha Theis, Sarita L. Karon

Year: 2019

Source:

Seibert J, Stockdale H, Feinberg R, Dobbins E, Theis E, Karon SL. State Policy Levers for Expanding Family-Centered Medication-Assisted Treatment 2019.

Publication Place: Washington, D.C.

Topic(s):

, , ,

Disclaimer:

Grey literature is comprised of materials that are not made available through traditional publishing avenues. Examples of grey literature in the Repository of the Academy for the Integration of Mental Health and Primary Care include: reports, dissertations, presentations, newsletters, and websites. This grey literature reference is included in the Repository in keeping with our mission to gather all sources of information on integration. Often the information from unpublished resources is limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

7589

State Strategies for Integrating Physical and Behavioral Health Services in a Changing Medicaid Environment

Type: Report

Authors: D. Bachrach, S. Anthony, A. Detty

Year: 2014

Source:

Bachrach D, Anthony S, Detty A. State Strategies for Integrating Physical and Behavioral Health Services in a Changing Medicaid Environment. New York, Ny: The Commonwealth Fund; 2014.

Publication Place: New York, NY

Abstract:

Drawing on a review of the literature and interviews with consumers, providers, payers, and policymakers, this report explores strategies states are deploying to address or eliminate system-level barriers to integrated care for a medically complex and high-cost Medicaid population.

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Reference Links: PDF (835.1 KB)

Export Citation: RIS

7590

State Telehealth Laws and Reimbursement Policies

Type: Report

Authors: Center for Connected Health Policy

Year: 2022

Source:

Policy C for CH. State Telehealth Laws and Reimbursement Policies. The National Telehealth Policy Resource Center; 2022.

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

7591

State Telehealth Laws and Reimbursement Policies At a Glance

Type: Report

Authors: Center for Connected Health Policy

Year: 2018

Source:

Policy C for CH. State Telehealth Laws and Reimbursement Policies At a Glance. Public Health Institute; 2018.

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Reference Links: PDF (419 KB)

Export Citation: RIS

7592

State Variation in Medicaid Prescriptions for Opioid Use Disorder from 2011 to 2018

Type: Report

Authors: Lisa Clemons-Cope, Victoria Lynch, Emma Winiski, Marni Epstein

Year: 2019

Source:

Clemons-Cope L, Lynch V, Winiski E, Epstein M. State Variation in Medicaid Prescriptions for Opioid Use Disorder from 2011 to 2018. Urban Institute; 2019.

Topic(s):

, , ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

7593

State-Based Commercial Insurers' COVID-19 Telehealth Policies

Type: Web Resource

Authors: American Psychological Association

Year: 2022

Source:

Association AP. State-Based Commercial Insurers' COVID-19 Telehealth Policies 2022.

Publication Place: Washington, D.C.

Topic(s):

, ,

Disclaimer:

Grey literature is comprised of materials that are not made available through traditional publishing avenues. Examples of grey literature in the Repository of the Academy for the Integration of Mental Health and Primary Care include: reports, dissertations, presentations, newsletters, and websites. This grey literature reference is included in the Repository in keeping with our mission to gather all sources of information on integration. Often the information from unpublished resources is limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

7594

State-by-State Health Home State Plan Amendment Matrix: Summary Overview

Type: Web Resource

Year: 2012

Source:

State-by-State Health Home State Plan Amendment Matrix: Summary Overview 2012.

Abstract:

This matrix outlines key program design features from draft health home State Plan Amendments (SPAs) submitted to the Centers for Medicare & Medicaid Services (CMS). This document captures what states have proposed in draft or final SPAs submitted as of January 2012.

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (416.93 KB)

Reference Links: PDF (416.93 KB)

Export Citation: RIS

7595

State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review

Type: Journal Article

Authors: F. L. Beaudoin, G. N. Banerjee, M. J. Mello

Year: 2016

Source:

Beaudoin FL, Banerjee GN, Mello MJ. State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review. Journal Of Opioid Management 2016;12:109-118, . https://doi.org/10.5055/jom.2016.0322.

Publication Place: United States

Abstract: OBJECTIVE: In response to persistent public health concerns regarding prescription opioids, many states and healthcare systems have implemented legislation and policies intended to regulate or guide opioid prescribing. The overall impact of these policies is still uncertain. The aim of this systematic review was to examine the existing evidence of provider-level and patient-level outcomes preimplementation and postimplementation of policies and legislation constructed to impact provider prescribing practices around opioid analgesics. DESIGN: A systematic search of MEDLINE, EMBASE, the Web of Science, and the Cochrane Database of Systematic Reviews was conducted to identify studies evaluating the impact of opioid prescribing policies on provider-level and patient-level outcomes. The systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. RESULTS: Eleven studies were included in the review. A meta-analysis was not possible due to between-study heterogeneity. Six of the studies assessed state-level policies, and five were at the level of the healthcare system or hospital. Studies showed temporal associations between policy implementation and reductions in opioid prescribing, as well as opioid-related overdoses. Results were mixed regarding the impact of policies on misuse. The majority of the studies were judged to be of low quality based on the GRADE criteria. CONCLUSIONS: There is low to moderate quality evidence suggesting that the presence of opioid prescribing policy will reduce the amount and strength of opioid prescribed. The presence of these policies may impact the number of overdoses, but there is no clear evidence to suggest that it reduces opioid misuse.

Topic(s):

,

Pubmed

Reference Links:

Pubmed

Export Citation: RIS

7596

State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder

Type: Journal Article

Authors: Amanda J. Abraham, Christina M. Andrews, Colleen M. Grogan, Harold A. Pollack, Thomas D'Aunno, Keith Humphreys, Peter D. Friedmann

Year: 2018

Source:

Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, et al. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatric Services (Washington, D.c.) 2018;69:448-455, . https://doi.org/10.1176/appi.ps.201700196.

Publication Place: United States

Abstract:

OBJECTIVE: As the United States grapples with an opioid epidemic, expanding access to effective treatment for opioid use disorder is a major public health priority. Identifying effective policy tools that can be used to expand access to care is critically important. This article examines the relationship between state-targeted funding and technical assistance and adoption of three medications for treating opioid use disorder: oral naltrexone, injectable naltrexone, and buprenorphine. METHODS: This study draws from the 2013-2014 wave of the National Drug Abuse Treatment System Survey, a nationally representative, longitudinal study of substance use disorder treatment programs. The sample includes data from 695 treatment programs (85.5% response rate) and representatives from single-state agencies in 49 states and Washington, D.C. (98% response rate). Logistic regression was used to examine the relationships of single-state agency targeted funding and technical assistance to availability of opioid use disorder medications among treatment programs. RESULTS: State-targeted funding was associated with increased program-level adoption of oral naltrexone (adjusted odds ratio [AOR]=3.14, 95% confidence interval [CI]=1.49-6.60, p=.004) and buprenorphine (AOR=2.47, 95% CI=1.31-4.67, p=.006). Buprenorphine adoption was also correlated with state technical assistance to support medication provision (AOR=1.18, 95% CI=1.00-1.39, p=.049). CONCLUSIONS: State-targeted funding for medications may be a viable policy lever for increasing access to opioid use disorder medications. Given the historically low rates of opioid use disorder medication adoption in treatment programs, single-state agency targeted funding is a potentially important tool to reduce mortality and morbidity associated with opioid disorders and misuse.

Topic(s):

,

Pubmed

Reference Links:

Pubmed

Export Citation: RIS

7597

Statement of the American Psychological Association in response to the "Joint principles: Integrating behavioral health care into the patient-centered medical home".

Type: Journal Article

Authors: Norman B. Anderson, Cynthia D. Belar, Barbara A. Cubic, Ellen G. Garrison, Suzanne Bennett Johnson, Nadine J. Kaslow

Year: 2014

Source:

Anderson NB, Belar CD, Cubic BA, Garrison EG, Johnson SB, Kaslow NJ. Statement of the American Psychological Association in response to the "Joint principles: Integrating behavioral health care into the patient-centered medical home". Families, Systems, & Health - Vol 32, Iss 2 2014. https://doi.org/10.1037/fsh0000051.

Topic(s):

Reference Links:

Export Citation: RIS

7598

Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction

Type: Journal Article

Authors: M. L. Kraus, D. P. Alford, M. M. Kotz, P. Levounis, T. W. Mandell, M. Meyer, E. A. Salsitz, N. Wetterau, S. A. Wyatt, American Society of Addiction Medicine

Year: 2011

Source:

Kraus ML, Alford DP, Kotz MM, Levounis P, Mandell TW, Meyer M, et al. Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. Journal Of Addiction Medicine 2011;5:254-263, . https://doi.org/10.1097/ADM.0b013e3182312983.

Publication Place: United States

Abstract: OBJECTIVES: Opioid addiction affects over 2 million patients in the United States. The advent of buprenorphine and the passage of the Drug Addiction Treatment Act in 2000 have revolutionized the opioid treatment delivery system by granting physicians the ability to administer office-based opioid treatment (OBOT), thereby giving patients greater access to treatment. The purpose of this consensus panel was to synthesize the most current evidence on the use of buprenorphine in the office-based setting and to make recommendations that will enable and allow additional physicians to begin to treat opioid-addicted individuals. METHODS: Literature published from 2000 to 2009 was searched using the PubMed search engine and yielded over 375 articles published in peer-reviewed journals, including some that were published guidelines. These articles were submitted to a consensus panel composed of researchers, educators, and clinicians who are leaders in the field of addiction medicine with specific expertise in the use of OBOT. The panel discussed results and agreed upon consensus recommendations for several facets of OBOT. RESULTS: : On the basis of the literature review and consensus discussions, the panel developed a series of findings, conclusions, and recommendations regarding the use of buprenorphine in office-based treatment of opioid addiction. CONCLUSIONS: Therapeutic outcomes for patients who self-select office-based treatment with buprenorphine are essentially comparable to those seen in patients treated with methadone programs. There are few absolute contraindications to the use of buprenorphine, although the experience and skill levels of treating physicians can vary considerably, as can access to the resources needed to treat comorbid medical or psychiatric conditions--all of which affect outcomes. It is important to conduct a targeted assessment of every patient to confirm that the provider has resources available to meet the patient's needs. Patients should be assessed for a broad array of biopsychosocial needs in addition to opioid use and addiction, and should be treated, referred, or both for help in meeting all their care needs, including medical care, psychiatric care, and social assistance. Current literature demonstrates promising efficacy of buprenorphine, though further research will continue to demonstrate its effectiveness for special populations, such as adolescents, pregnant women, and other vulnerable populations. Since the time of this review, several new studies have provided new data to continue to improve our understanding of the safety and efficacy of buprenorphine for special patient populations.

Topic(s):

,

Pubmed

Reference Links:

Pubmed

Export Citation: RIS

7599

States Tackling Health Care System Transformation with Federal Support

Type: Report

Authors: Jennifer Lloyd, Stephanie Kissam, Allison Pompey

Year: 2019

Source:

Lloyd J, Kissam S, Pompey A. States Tackling Health Care System Transformation with Federal Support. Milbank Memorial Fund; 2019.

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

7600

States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence

Type: Journal Article

Authors: Hannah K. Knudsen, Michelle R. Lofwall, Jennifer R. Havens, Sharon L. Walsh

Year: 2015

Source:

Knudsen HK, Lofwall MR, Havens JR, Walsh SL. States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence. Drug And Alcohol Dependence 2015;157:36-43, .

Topic(s):

Export Citation: RIS